Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-ichi Hanada

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|July 3, 2020
Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the ThymusFrançois Van Laethem, Ingrid Saba, Jinghua Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Immunity|January 3, 2012
αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificitiesAnastasia N Tikhonova, François Van Laethem, Ken-ichi Hanada, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2021
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung AdenocarcinomaYue A Qi, Tapan K Maity, Constance M Cultraro, et al.
The Journal of Clinical Investigation|February 23, 2008
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cellsYoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
Journal for Immunotherapy of Cancer|May 6, 2026
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical responseAlexandra M Gustafson, Aarushi Bhasin, Billel Gasmi, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|July 3, 2020
Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the ThymusFrançois Van Laethem, Ingrid Saba, Jinghua Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Immunity|January 3, 2012
αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificitiesAnastasia N Tikhonova, François Van Laethem, Ken-ichi Hanada, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2021
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung AdenocarcinomaYue A Qi, Tapan K Maity, Constance M Cultraro, et al.
The Journal of Clinical Investigation|February 23, 2008
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cellsYoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
Journal for Immunotherapy of Cancer|May 6, 2026
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical responseAlexandra M Gustafson, Aarushi Bhasin, Billel Gasmi, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
Pageof 4